All terms
    Investment & FinanceStartup Lifecycle

    Super Pro Rata Rights

    A contractual right allowing an investor to purchase more than its current ownership percentage in a future financing round, beyond a standard pro-rata right.

    Reviewed by Christian Espinosa, Founder, Blue Goat CyberLast reviewed September 19, 2026

    Definition

    Super pro rata rights (sometimes called over-allotment or preferential rights) allow an investor to participate in future financing rounds by purchasing more shares than a standard pro-rata right would allow, letting the investor increase its ownership percentage over time rather than merely maintain it. A standard pro-rata right lets an investor buy enough new shares in a subsequent round to keep its existing ownership percentage from being diluted; a super pro-rata right specifies a multiple (for example, 1.5x or 2x its current ownership) or a fixed target percentage the investor may purchase up to, subject to the round's overall size and other investors' rights.

    What this means in practice

    In MedTech, where a company may raise a modest seed round before pivotal data exist and then a much larger Series A or B once clinical or regulatory milestones de-risk the story, an early investor with conviction often negotiates super pro-rata rights to concentrate more capital into the company at the moment its risk profile most improves, rather than being capped at maintaining its original, smaller percentage.

    Examples

    • A seed investor owns 8 percent of the company after investing $1,000,000 in a $12,500,000 post-money round. A standard pro-rata right lets that investor invest enough in the Series A to keep 8 percent ownership. A 2x super pro-rata right lets the investor instead invest enough to reach up to 16 percent ownership in the Series A, subject to the round's total size and allocation to new investors.
    • If the Series A is sized at $20,000,000 and the investor's 2x super pro-rata right entitles it to up to 16 percent of that round, the investor could invest up to $3,200,000 (16 percent of $20,000,000), compared with roughly $1,600,000 under a standard pro-rata right sized to maintain its original 8 percent.
    Common pitfalls
    • Assuming super pro-rata rights are automatically honored regardless of round size; term sheets typically cap the right by the round's total allocation and may be subordinated to new lead investors' allocation needs.
    • Failing to disclose an existing super pro-rata right to a new lead investor early in negotiations, which can create friction over final round allocation late in the process.
    • Confusing super pro-rata rights with a right of first refusal on secondary sales; they govern participation in new primary issuances, not the purchase of existing stockholders' shares.

    Frequently asked questions

    Lead investors in early rounds, or investors who take on outsized risk relative to round size (such as a seed lead backing a MedTech company well before pivotal data exist), most commonly negotiate super pro-rata rights as part of their investment terms.
    Grouped by theme
    Cited by

    Where this term appears across MedTech Terms.

    Ecosystems (1)

    Sources

    3 sources

    Every citation below opens the original document. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.

    Tier 2Regulator guidance and consensus· 1Tier 4Trade press and expert commentary· 2
    Link health: 2 verified 1 unchecked· last checked 2026-06-20
    SEC Investor.gov·1NVCA·1SVB·1
    1. 1
      SEC Investor.gov: Venture Capital
      Tier 2 Unchecked
      SEC Investor.govinvestor.gov
    2. 2
      NVCA Model Investors' Rights Agreement
      Tier 4 Verified
      NVCAnvca.org
    3. 3
      Silicon Valley Bank - Healthcare Reports
      Tier 4 Verified
      SVBsvb.com

    Inline markers like [1] jump to the matching reference above.